Endothelial Growth Factors
Showing 1 - 25 of >10,000
Macular Disease Trial in Omaha
Suspended
- Macular Disease
-
Omaha, Nebraska
- +1 more
Sep 16, 2022
Exudative Age-related Macular Degeneration Trial (intravitreal injection)
Completed
- Exudative Age-related Macular Degeneration
- intravitreal injection
- (no location specified)
Apr 19, 2022
Refractory Angina Pectoris, Gene Transfer, Coronary Artery Disease Trial in Copenhagen, Kuopio (AdvVEGF-D, Control Rx)
Recruiting
- Refractory Angina Pectoris
- +2 more
- AdvVEGF-D
- Control Rx
-
Copenhagen, Denmark
- +1 more
Oct 19, 2022
Adult Diabetic Macular Edema and Suboptimal Response to
Not yet recruiting
- Diabetic Macular Edema
- (no location specified)
Jul 31, 2023
Iris Trial in Assiut (Immunohistochemistry analysis)
Not yet recruiting
- Iris
- Immunohistochemistry analysis
-
Assiut, EgyptHassan Lotfy
Jul 29, 2022
Effect of Plasma Rich in Growth Factors on Semen Quality
Completed
- Vascular Endothelial Growth Factor Overexpression
- PRGF in candidates for sperm donors
-
Leioa, Vizcaya, Spain
- +2 more
Jul 29, 2022
Diabetic Macular Edema, Cataract Trial in Walnut Creek (Bevacizumab, Ranibizumab, Aflibercept)
Recruiting
- Diabetic Macular Edema
- Cataract
- Bevacizumab
- +3 more
-
Walnut Creek, CaliforniaBay Area Retina Associates
Mar 1, 2022
Diarrhea, Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Duarte (other, dietary supplement, drug)
Active, not recruiting
- Diarrhea
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 7, 2022
Retinal Vein Occlusion Trial in Winston-Salem (Aflibercept Ophthalmic)
Recruiting
- Retinal Vein Occlusion
- Aflibercept Ophthalmic
-
Winston-Salem, North CarolinaWake Forest Health Sciences
Jan 5, 2022
Intravitreal Injection Site and Perceived Pain
Recruiting
- Pain
- Intravitreal injection site
-
Galveston, TexasUniversity of Texas Medical Branch
Jan 19, 2023
Macular Edema Due to Type 2 Diabetes Trial in Hangzhou (Anti-VEGF, subthreshold micropulse laser)
Recruiting
- Macular Edema Due to Type 2 Diabetes Mellitus
- Anti-VEGF
- subthreshold micropulse laser
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital, School of Medicine, Zhejiang Univers
Feb 26, 2023
Neovascular Age-related Macular Degeneration(nAMD) Trial in Shanghai, Tianjin (HG202)
Not yet recruiting
- Neovascular Age-related Macular Degeneration(nAMD)
- HG202
-
Shanghai, Shanghai, China
- +1 more
Sep 4, 2023
Analgesia Methods on Vascular Endothelial Growth Factor* and
Completed
- Breast Cancer
- Morphine
- +2 more
-
Ankara, TurkeyDr.Abdurrahman Yurtaslan Ankara Oncology Train and Research Hosp
Oct 21, 2021
Exudative Age Related Macular Degeneration Trial in Winston-Salem (Ranibizumab, Photodynamic laser treatment (PDT),
Not yet recruiting
- Exudative Age Related Macular Degeneration
- Ranibizumab
- +3 more
-
Winston-Salem, North CarolinaWake Forest Health Sciences
Nov 28, 2022
Uveitis, Macular Edema, Vascular Endothelial Growth Factor Trial in Beijing (intravitreal injection of Conbercept)
Terminated
- Uveitis
- +3 more
- intravitreal injection of Conbercept
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital (PUMCH)
Oct 24, 2022
Ocular Adverse Events in Neovascular Age-related Macular
Completed
- Age-related Macular Degeneration (AMD)
- Aflibercept
- +2 more
-
East Hanover, New JerseyNovartis Investigative Site
Dec 15, 2021
Diabetic Macular Edema, Age-Related Macular Degeneration, Choroidal Neovascularization Trial in Banha (Anti-vascular endothelial
Recruiting
- Diabetic Macular Edema
- +4 more
- Anti-vascular endothelial growth factors (Anti-VEGFs)
-
Banhā, Benha, EgyptAhmed Abdelshafy Tabl
Aug 8, 2022
Evaluation of New Biomarkers in Stage 3 and 4 Endometriosis
Completed
- Endometriosis
- endometriosis surgery
- other benign condition surgeries
-
Istanbul, Bagcilar, TurkeyBagcilar Teaching and Research Hospital
Mar 26, 2022
Neovascular Age-related Macular Degeneration (nAMD) Trial (AR-14034 SR implant lower dose, Aflibercept Injection, Sham
Not yet recruiting
- Neovascular Age-related Macular Degeneration (nAMD)
- AR-14034 SR implant lower dose
- +3 more
- (no location specified)
Mar 3, 2023
Growth Hormone Deficiency Trial in New York (Blood draws, Growth hormone releasing hormone (GHRH) and arginine, Carotid
Terminated
- Growth Hormone Deficiency
- Blood draws
- +4 more
-
New York, New YorkColumbia University, College of Physicians and Surgeons
Oct 24, 2022
Anti-VEGF in Real-world
Recruiting
- Neovascular Age-related Macular Edema
- +5 more
- Ranibizumab
- +2 more
-
Beijing, Beijing, ChinaWen-Bin Wei
Feb 2, 2022
Maternal Serum Vascular Endothelial Growth Factor in Pregnant
Recruiting
- Foetal Growth Restriction
- obstetric Ultrasound
- serum Vascular Endothelial Growth Factor
-
Cairo, EgyptNesreen Abdel Fattah Abdullah Shehata
Jan 30, 2021